Senior/Staff Linux Software Engineer – Robotics Platform
Neptune Medical1 year ago
Burlingame, CA, USASenior / Staff+
H1B sponsor
Base Salary
$185k - $225k/yr
Responsibilities
- Design and implement the compute platform for the Triton robot’s vision pipeline.
- Evaluate and prototype control and vision subsystem solutions using different computers and GPUs, optimizing latency, efficiency, and robustness.
- Develop, document, verify, and improve video pipeline software on NVIDIA Jetson embedded systems, including camera control, low-latency display, video recording, stream compositing, and camera metadata sharing.
- Collaborate with deep-learning and computer-vision engineers to integrate new processing capabilities and AI applications into product software.
- Participate in software design and code reviews with peer engineers.
- Document software designs, reviews, and processes.
Requirements
- B.S. or M.S. in computer science, computer engineering, electrical engineering, or a related field.
- 5–7 years of experience designing and developing software applications for embedded Linux systems.
- Robust knowledge of C++ and Python.
- Experience with Linux kernel development and/or NVIDIA’s embedded software stack is desired.
- Ability to handle multiple responsibilities within a fast-paced software team.
- Excellent communication and documentation skills.
Benefits
- Starting base salary is $185,000–$225,000 depending on experience.
- May be eligible for equity, benefits, and a 401(K) with matching.
- The role is located in Burlingame, California, near the Millbrae Caltrain and BART Station.
About Neptune Medical
Neptune Medical designs, manufactures, and sells devices for flexible endoscopy, including the FDA-cleared Pathfinder platform powered by its Dynamic Rigidization technology, used in U.S. hospitals. The company is developing Triton, a fully flexible robotic endoscopy system for deep gastrointestinal access. Privately held and venture-backed since its 2016 founding, Neptune is headquartered in Burlingame, California, and commercializes medical devices for gastroenterologists and endoscopy centers, with a Series D financing completed in 2024.